BioHarvest Sciences Inc. Common Stock (BHST) - Cash Flow Conversion Efficiency
Based on the latest financial reports, BioHarvest Sciences Inc. Common Stock (BHST) has a cash flow conversion efficiency ratio of -0.140x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.77 Million) by net assets ($19.76 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of BioHarvest Sciences Inc. Common Stock for the company's overall valuation and market capitalisation.
BioHarvest Sciences Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2015–2025)
This chart illustrates how BioHarvest Sciences Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data.
BioHarvest Sciences Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of BioHarvest Sciences Inc. Common Stock ranked by their cash flow conversion efficiency. Explore how high is BioHarvest Sciences Inc. Common Stock's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ananda Development Public Company Limited
BK:ANAN
|
0.067x |
|
Liberty Shoes Limited
NSE:LIBERTSHOE
|
0.117x |
|
Development Advance Solution Co Ltd
KO:058730
|
0.022x |
|
Jinxin Technology Holding Company American Depositary Shares
NASDAQ:NAMI
|
0.019x |
|
Canlan Ice Sports Corp.
TO:ICE
|
0.085x |
|
U.C.A. AG O.N.
F:UCA1
|
N/A |
|
Aldoro Resources Ltd
AU:ARN
|
-0.048x |
|
FOODWELL Co. Ltd
KQ:005670
|
0.092x |
Annual Cash Flow Conversion Efficiency for BioHarvest Sciences Inc. Common Stock (2015–2025)
The table below shows the annual cash flow conversion efficiency of BioHarvest Sciences Inc. Common Stock from 2015 to 2025. View latest BioHarvest Sciences Inc. Common Stock stock price today for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $25.45 Million | $-7.23 Million | -0.284x | +94.35% |
| 2024-12-31 | $1.33 Million | $-6.68 Million | -5.026x | -975.91% |
| 2023-12-31 | $-14.85 Million | $-8.52 Million | 0.574x | -63.19% |
| 2022-12-31 | $-5.93 Million | $-9.24 Million | 1.559x | +165.50% |
| 2021-12-31 | $2.85 Million | $-6.79 Million | -2.380x | -240.94% |
| 2020-12-31 | $-2.29 Million | $-3.88 Million | 1.688x | +1810.94% |
| 2019-12-31 | $-26.97 Million | $-2.38 Million | 0.088x | +2521.42% |
| 2017-12-31 | $274.05K | $-1.00K | -0.004x | -100.29% |
| 2016-12-31 | $-59.57K | $-74.60K | 1.252x | +115.88% |
| 2015-12-31 | $16.09K | $-126.82K | -7.884x | -- |
About BioHarvest Sciences Inc. Common Stock
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and w… Read more